Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Trump administration has rejected Biden proposal to expand coverage Medicare currently covers Ozempic, Mounjaro solely for diabetes Wegovy, Zepbound not covered for weight loss Trump ...

(NewsNation) — Millions of Americans fighting obesity faced a setback last month when the Trump administration declined to allow Medicare and Medicaid to cover popular weight loss drugs like ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But access remains limited.

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look at the issue with Dr. Anand Parekh of the Bipartisan Policy Center.

You may also need to provide evidence that other weight loss methods were not effective. Medicare will cover weight loss surgery for people who meet the criteria, which include having a BMI of 35 ...

"So this is not just the weight loss, it's also health indicators ... under Biden to expand coverage to these drugs under Medicare, the Trump administration pulled back on that, and a lot ...